pubmed.ncbi.nlm.nih.gov

Privileged scaffolds for library design and drug discovery - PubMed

Review

Privileged scaffolds for library design and drug discovery

Matthew E Welsch et al. Curr Opin Chem Biol. 2010 Jun.

Abstract

This review explores the concept of using privileged scaffolds to identify biologically active compounds through building chemical libraries. We hope to accomplish three main objectives: to provide one of the most comprehensive listings of privileged scaffolds; to reveal through four selected examples the present state of the art in privileged scaffold library synthesis (in hopes of inspiring new and even more creative approaches); and also to offer some thoughts on how new privileged scaffolds might be identified and exploited.

PubMed Disclaimer

Figures

**Figure 1**
A potential privileged scaffold found in natural products?

**Scheme 1**
Synthesis of 1,4-benzodiazepine library *Reagents and conditions*: (a) 20% piperidine in DMF; (b) N-Fmoc-amino acid fluoride in CH₂Cl₂; (c) 5% acetic acid in DMF; (d) lithiated 5-phenylmethyl-2-oxazolidinone in DMA/THF, 1:10 (v/v); alkylating agent in DMF; (e) TFA/H₂O/Me₂S, 95:5:10 (v/v).

**Scheme 2**
Solid phase synthesis of 2,6,9-substituted purine library Reagents and conditions: (a) p-methoxybenzylamine, NaBH(OAc)₃, AcOH (2%), DMF, 25 °C; (b) SEM-Cl (1.2 eq), DIEA, DMF, 0→25 °C; (c) DIEA, n-BuOH-DMSO (1:1), 7; (d) TBAF (0.25 M), THF, 60 °C; (e) i-PrOH (0.5 M), DIAD (0.5 M), Ph₃P (1.0 M), THF/CH₂Cl₂ (1/1); (f) 3-amino-1-propanol, DIEA, N-methylpyrrolidinone, 110 °C; (g) TFA-H₂O (95:5), 25 °C.

**Scheme 3**
Two alternative solution phase routes for purine library synthesis *Reagents and conditions*: (a) R¹OH (2 equiv), DEAD (1.1 equiv), Ph₃P (2 equiv), THF, -10→25 °C; (b) (CF₃)₂O, CH₂Cl₂, 0→25 °C; (c) R²OH (2 equiv), DEAD (1 equiv), Ph₃P (2 equiv), THF, 0→25 °C; K₂CO₃, MeOH; (d) R3R4NH (4 equiv), DIEA, n-BuOH, 110 °C; AcOH/H₂O/THF (3/1/1); (e) R1OH (1.2 equiv), DEAD (1.3 equiv), Ph₃P (1.3 equiv), THF, -10→25 °C; (f) R²R³NH (1 equiv), DIEA, n-BuOH, 140 °C; (g) R⁴NH₂ (1.5 equiv), DIEA, n-BuOH, 150–170 °C.

**Scheme 4**
Synthesis of amide and amine-based 2-arylindole libraries. *Reagents and conditions:* (a) DIC, THF/CH₂Cl₂ followed by resin and 4-DMAP; (b) archive, mix and split resin; (c) aryl hydrazine, ZnCl₂, AcOH; (d) pentafluorobenzyl alcohol, Ph₃P, DIAD, THF; (e) R₂R₃NH; (f) polystyryl isothiocyanate resin; (g) BMS, dioxane, 50 °C; (h) HCl/MeOH, 50 °C then azeotrope.

**Scheme 5**
Initial aldehyde scaffold for 3,3-dimethylbenzopyran library synthesis; schemes illustrates key branching point where organometallic addition, reductive amination and Knoevangel condensation can then occur.

Cited by

Iron-catalyzed α-C-H functionalization of π-bonds: cross-dehydrogenative coupling and mechanistic insights.
Wang Y, Zhu J, Guo R, Lindberg H, Wang YM. Wang Y, et al. Chem Sci. 2020 Oct 16;11(45):12316-12322. doi: 10.1039/d0sc05091a. Chem Sci. 2020. PMID: 34094439 Free PMC article.
The chemistry and pharmacology of privileged pyrroloquinazolines.
Chao B, Li BX, Xiao X. Chao B, et al. Medchemcomm. 2015 Apr 1;6(4):510-520. doi: 10.1039/C4MD00485J. Medchemcomm. 2015. PMID: 25937878 Free PMC article.
Aminoboration: Addition of B-N σ Bonds across C-C π Bonds.
Chong E, Blum SA. Chong E, et al. J Am Chem Soc. 2015 Aug 19;137(32):10144-7. doi: 10.1021/jacs.5b06678. Epub 2015 Aug 10. J Am Chem Soc. 2015. PMID: 26238962 Free PMC article.
Water-triggered union of multi-component reactions towards the synthesis of a 4H-chromene hybrid scaffold.
Kumaravel K, Rajarathinam B, Vasuki G. Kumaravel K, et al. RSC Adv. 2020 Aug 6;10(49):29109-29113. doi: 10.1039/d0ra05105e. eCollection 2020 Aug 5. RSC Adv. 2020. PMID: 35521150 Free PMC article.
Aromatic Rings Commonly Used in Medicinal Chemistry: Force Fields Comparison and Interactions With Water Toward the Design of New Chemical Entities.
Polêto MD, Rusu VH, Grisci BI, Dorn M, Lins RD, Verli H. Polêto MD, et al. Front Pharmacol. 2018 Apr 24;9:395. doi: 10.3389/fphar.2018.00395. eCollection 2018. Front Pharmacol. 2018. PMID: 29740321 Free PMC article.

References

1. Stockwell BR. Exploring biology with small organic molecules. Nature. 2004;432:846–54. - PMC - PubMed
1. Stockwell BR. Chemical genetics: ligand-based drug discovery of gene function. Nat Rev Genet. 2000;1:116–25. - PMC - PubMed
1. Payne DJ, Gwynn MN, Holmes DJ, Pomplinano DL. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nature Reviews Drug Discovery. 2007;6:29–40. - PubMed
1. Breinbauer R, Vetter IR, Waldmann H. From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries. Angew Chem Int Ed. 2002;41:2878–2890. The authors discuss natural products as a biologically validated starting point for library construction. They analyze rational library design in the context of structural biology and bioinformatics. - PubMed
1. Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL, Lundell GF, Veber DF, Anderson PS, Chang RSL, Lotti VJ, Cerino DJ, Chen TB, Kling PJ, Kunkel KA, Springer JP, Hirshfield J. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem. 1988;31:2235–2246. - PubMed

Privileged scaffolds for library design and drug discovery - PubMed